Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Current State of Charcot-Marie-Tooth Disease Treatment.

Genes - 1 Jul 2023

Okamoto Yuji, Takashima Hiroshi

Abstract excerpt

Charcot-Marie-Tooth disease (CMT) and associated neuropathies are the most predominant genetically transmitted neuromuscular conditions; however, effective pharmacological treatments have not established. The extensive genetic heterogeneity of CMT, which impacts the peripheral nerves and causes lifelong disability, presents a significant barrier to the development of comprehensive treatments. An estimated 100...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium
Share to Charcot-Marie-Tooth Disease
Share to Gene Silencing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to Hereditary Neurological Disorders

Share to Intracellular Space

Share to Mutation

Share to Peripheral Neuropathies and Disorders

Source

Open in PubMed Open full text

Identifiers

PMID: 37510296
DOI: 10.3390/genes14071391
PMCID: PMC10379063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Current State of Charcot-Marie-Tooth Disease Treatment.PMID 37510296Read ↗

The Current State of Charcot–Marie–Tooth Disease TreatmentSemantic proximity Read ↗

Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies.Semantic proximity Read ↗

Current Treatment Methods for Charcot–Marie–Tooth DiseasesSemantic proximity Read ↗

Charcot-Marie-Tooth: From Molecules to TherapySemantic proximity Read ↗

Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease.Semantic proximity Read ↗

Treatment of Charcot-Marie-Tooth neuropathies.Semantic proximity Read ↗

Challenges in Treating Charcot-Marie-Tooth Disease and Related Neuropathies: Current Management and Future PerspectivesSemantic proximity Read ↗

Charcot-Marie-Tooth neuropathies: Current gene therapy advances and the route toward translation.Semantic proximity Read ↗

A brief review of recent Charcot-Marie-Tooth research and prioritiesSemantic proximity Read ↗

Update on Charcot-Marie-Tooth disease.Semantic proximity Read ↗

Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies.Semantic proximity Read ↗

Charcot-Marie-Tooth disease: an overview of genotypes, phenotypes, and clinical management strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.